Skip to main content
Synergus
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Contact Us
IGES group
RWE impact
Data that makes the difference
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Countries
Diagnostics
Digital Health
Medical Device
Market access strategy
Hands-on market access support
Reimbursement dossier / HTA dossier
Reimbursement/DRG analysis
Pharma
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Contact Us
RWE impact
Data that makes the difference
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Countries
Diagnostics
Digital Health
Medical Device
Market access strategy
Reimbursement/DRG analysis
Reimbursement dossier / HTA dossier
Hands-on market access support
Pharma
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
Blog
Unlocking Real-World Evidence utilising lab results – case study in Kidney disease in Denmark
02 Jun 2025
Tags:
RWD_DK
Denmark
read more
Integration of Treatment council to The Danish Healthcare Quality Institute (DHQI) - Impacting Medtech and Diagnostics
23 May 2025
Tags:
RWD_DK
HTA
read more
EU HTA for IVD's
22 Apr 2025
Tags:
EU HTAR IVD
read more
EU HTA for Medtech
14 Apr 2025
Tags:
EU HTAR Medtech
read more
Germany is introducing 20 % performance-based pricing on digital health
28 May 2024
Tags:
Real World Evidence
DHS Germany
read more
Real-World data provide essential insights about Myeloma
23 May 2024
Tags:
Sweden
Myeloma
Real World Evidence
read more
R-RCT from the Obesity registry resolve uncertainty about comparative effectiveness
28 Apr 2024
Tags:
Sweden
R-RCT
Obesity
read more
Swedish drug registry – Data since 2005 and perfect linkage to other datasets
13 Apr 2024
Tags:
Sweden
Real World Evidence
read more
Denmark Aims for "Digital First"
02 Jan 2024
Tags:
Denmark
Digital Health
read more
Class IIb and III – Clarify Eligibility for 137 (h) prior to submitting NUB in Germany!
17 Sep 2023
Tags:
Germany
Coverage with Evidence Development
Medical Device
read more
Show More
Contact us
Tags
Breast cancer
Corona virus
DHS France
EMA
EQ-5D
EU HTAR
EU HTAR IVD
EU HTAR Medtech
Germany
HQ_RWD
Imaging
Myeloma
Obesity
Patient Registries
Pharma
RWD Scientific Impact
RWD_DK
Transferability of Outcomes
Coverage with Evidence Development
DHS Germany
Italy
Melanoma
Multiple Sclerosis
Quality of Life
R-RCT
Registries
SF-36
DHS Belgium
Funding
HQRWE_Fracture
Netherlands
Rheumatoid Arthritis
Throat Cancer
Co-payment
Empowered Patients
Lung Cancer
Norway
Stroke
Digital Heath Strategies
France
Innovation Funding
Mental Health
Data Science in Oncology
Finland
Heart Failure
Out-patient procedures
Artificial Intelligence
Denmark
Diabetes
Dementia
Sweden
Alzheimer
The Netherlands
Oncology
United Kingdom
Country specific
China
COVID-19
Value Based Healthcare
HTA
RefugeeMD
Medical Device
Disease Specific
Health Economics
Legislation
Market Access
IVD
Digital Health
Real World Data
Real World Evidence